The immunohistochemical diagnosis of epithelial mesothelioma

Cadherin Cell Adhesion Receptors as a Morphogenetic Regulator

1991 • 3,314 citations

CD44 is the principal cell surface receptor for hyaluronate

1990 • 2,433 citations

CD44 and Its Interaction with Extracellular Matrix

1993 • 1,082 citations

Calcium-binding proteins: selective markers of nerve cells

1993 • 699 citations

CD44 — A molecule involved in leukocyte adherence and T-cell activation

1989 • 559 citations

Spatial and temporal expression pattern of N-cadherin cell adhesion molecules correlated with morphogenetic processes of chicken embryos

1987 • 510 citations

Expression and modulation of CD44 variant isoforms in humans

1994 • 436 citations

Calretinin: A Novel Immunocytochemical Marker for Mesothelioma

1996 • 434 citations

Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma.

1993 • 398 citations

Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelial.

1990 • 388 citations

Human keratinocytes express a new CD44 core protein (CD44E) as a heparan-sulfate intrinsic membrane proteoglycan with additional exons.

1991 • 377 citations

Molecular cloning and characterization of OB-cadherin, a new member of cadherin family expressed in osteoblasts.

1994 • 274 citations

Characterization of a polyclonal antiserum against the purified human recombinant calcium binding protein calretinin

1993 • 263 citations

Role of Immunohistochemistry in Distinguishing Epithelial Peritoneal Mesotheliomas From Peritoneal and Ovarian Serous Carcinomas

1998 • 210 citations

Wilms' tumor 1 susceptibility (WT1) gene products are selectively expressed in malignant mesothelioma.

1995 • 197 citations

Value of Cytokeratin 5/6 Immunostaining in Distinguishing Epithelial Mesothelioma of the Pleura From Lung Adenocarcinoma

1998 • 192 citations

Cytokeratins in normal lung and lung carcinomas

1984 • 181 citations

Differential expression of N‐ and R‐cadherin in functional neuronal systems and other structures of the developing chicken brain

1993 • 166 citations

Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma

1993 • 164 citations

Unstable Expression of E‐Cadherin Adhesion Molecules in Metastatic Ovarian Tumor Cells

1989 • 157 citations

Keratin proteins and carcinoembryonic antigen in lung carcinoma: An immunoperoxidase study of fifty-four cases, with ultrastructural correlations

1983 • 147 citations

Malignant epithelioid pleural mesothelioma versus peripheral pulmonary adenocarcinoma: A histochemical, ultrastructural, and immunohistologic study of 103 cases

1990 • 144 citations

Ber-EP4 Antibody as a Discriminant in the Differential Diagnosis of Malignant Mesothelioma Versus Adenocarcinoma

1991 • 139 citations

The intermediate filament cytoskeleton of malignant mesotheliomas and its diagnostic significance.

1985 • 136 citations

Immunohistochemical staining for keratin and carcinoembryonic antigen in the diagnosis of malignant mesothelioma

1984 • 130 citations

Value of calretinin immunostaining in differentiating epithelial mesothelioma from lung adenocarcinoma.

1998 • 129 citations

Thrombomodulin expression in malignant pleural mesothelioma and pulmonary adenocarcinoma.

1992 • 125 citations

The differential expression of N-cadherin and E-cadherin distinguishes pleural mesotheliomas from lung adenocarcinomas

1995 • 123 citations

Immunoreactivity for BER-EP4 in Adenocarcinomas, Adenomatoid Tumors, and Malignant Mesotheliomas

1992 • 122 citations

WT1 MUTATION IN MALIGNANT MESOTHELIOMA AND WT1 IMMUNOREACTIVITY IN RELATION TOp53 AND GROWTH FACTOR RECEPTOR EXPRESSION, CELL-TYPE TRANSITION, AND PROGNOSIS

1997 • 120 citations

The diagnostic distinction between malignant mesothelioma of the pleura and adenocarcinoma of the lung as defined by a monoclonal antibody (B72.3)

1987 • 117 citations

Expression of keratin 5 as a distinctive feature of epithelial and biphasic mesotheliomas

1989 • 116 citations

Anti‐cytokeratin 5/6: a positive marker for epithelioid mesothelioma

1997 • 110 citations

E‐cadherin and calretinin: a useful combination of immunochemical markers for differentiation between mesothelioma and metastatic adenocarcinoma

1998 • 109 citations

The role of the cell-cell adhesion molecule E-cadherin in large bowel tumour cell invasion and metastasis

1993 • 109 citations

SCLC-cluster-2 antibodies detect the pancarcinoma/epithelial glycoprotein EGP-2

1994 • 108 citations

N-Cadherin Involvement in Cardiac Myocyte Interaction and Myofibrillogenesis

1994 • 98 citations

Calretinin

1997 • 96 citations

Expression of E-cadherin and N-cadherin in surface epithelial-stromal tumors of the ovary distinguishes mucinous from serous and endometrioid tumors

1997 • 94 citations

Regulation of E-cadherin-mediated adhesion by muscarinic acetylcholine receptors in small cell lung carcinoma.

1993 • 91 citations

The Value of Antibodies 44-3A6, SM3, HBME-1, and Thrombomodulin in Differentiating Epithelial Pleural Mesothelioma From Lung Adenocarcinoma

1997 • 91 citations

Differential expression of N-cadherin in pleural mesotheliomas and E-cadherin in lung adenocarcinomas in formalin-fixed, paraffin-embedded tissues

1997 • 90 citations

Wilms' tumor suppressor gene expression in rat and human mesothelioma.

1994 • 89 citations

Immunohistochemical evaluation of seven monoclonal antibodies for differentiation of pleural mesothelioma from lung adenocarcinoma

1991 • 84 citations

A comparative evaluation of immunohistochemical markers for the differential diagnosis of malignant pleural tumours

1998 • 84 citations

Value of the MOC-31 monoclonal antibody in differentiating epithelial pleural mesothelioma from lung adenocarcinoma

1998 • 84 citations

Diagnosis of diffuse malignant mesothelioma: experience of a US/Canadian Mesothelioma Panel.

1991 • 82 citations

Mucin-Positive Epithelial Mesotheliomas: A Histochemical, Immunohistochemical, and Ultrastructural Comparison with Mucin-Producing Pulmonary Adenocarcinomas

1996 • 82 citations

Markers for metastatic adenocarcinoma in serous effusion specimens

1994 • 82 citations

Immunohistochemical phenotype of malignant mesothelioma: predictive value of CA125 and HBME‐1 expression

1997 • 76 citations

ANTIGENS OF SMALL-CELL LUNG CANCER

1987 • 76 citations

Value of thrombomodulin immunostaining in the diagnosis of mesothelioma

1997 • 74 citations

Mesothelioma‐binding antibodies: thrombomodulin, OV 632 and HBME‐1 and their use in the diagnosis of malignant mesothelioma

1996 • 71 citations

Immunohistological study of malignant diffuse mesotheliomas of the pleura

1984 • 70 citations

Expression of the calcium binding protein calretinin in WiDr cells and its correlation to their cell cycle

1992 • 68 citations

Diffuse Malignant Mesothelioma of Pleura: Diagnostic Criteria Based on an Autopsy Study

1984 • 64 citations

Diagnostic tools for differentiating between pleural mesothelioma and lung adenocarcinoma in paraffin embedded tissue. Part I: immunohistochemical findings

1993 • 61 citations

Application of Monoclonal Antibodies in Tumor Pathology

1987 • 59 citations

Immunocytochemistry of malignant mesothelioma: OV632 as a marker of malignant mesothelioma

1991 • 59 citations

Pleural mesothelioma of epithelial type and pulmonary adenocarcinoma: An ultrastructural and cytochemical comparison

1987 • 58 citations

Calretinin: a novel tool for diagnostic immunohistochemistry.

1998 • 56 citations

Immunocytochemistry in the differential diagnosis of effusions: use of logistic regression to select a panel of antibodies to distinguish adenocarcinomas from mesothelial proliferations.

1993 • 56 citations

Expression of CD44 standard form and variant isoforms in non-small cell lung carcinomas

1997 • 52 citations

Thrombomodulin is a new biological and prognostic marker for breast cancer: an immunohistochemical study.

1997 • 50 citations

HBME-1 and antithrombomodulin in the differential diagnosis of malignant mesothelioma of pleura.

1997 • 50 citations

Anti-MOC-31: a potential addition to the pulmonary adenocarcinoma versus mesothelioma immunohistochemistry panel.

1997 • 49 citations

Monoclonal antibody Ber‐EP4: Its use in the differential diagnosis of malignant mesothelioma and carcinoma in cell blocks of malignant effusions and FNA specimens

1994 • 48 citations

OV 632 and MOC 31 in the diagnosis of mesothelioma and adenocarcinoma: an assessment of their use in formalin fixed and paraffin wax embedded material.

1995 • 48 citations

Malignant mesotheliomas. Improved differential diagnosis from lung adenocarcinomas using monoclonal antibodies 44-3A6 and 624A12.

1986 • 45 citations

Production of endothelin-1 and thrombomodulin by human pancreatic cancer cells

1994 • 43 citations

Immunohistochemical reactivity in mesothelioma and adenocarcinoma: A stepwise logistic regression analysis

1994 • 43 citations

Blood group antigens, Lewisx and Lewisy in the diagnostic discrimination of malignant mesothelioma versus adenocarcinoma.

1989 • 42 citations

CD44H expression in reactive mesothelium, pleural mesothelioma and pulmonary adenocarcinoma

1997 • 41 citations

Immunoperoxidase staining on frozen tissue sections as a first screening assay in the preparation of monoclonal antibodies directed against small cell carcinoma of the lung

1984 • 40 citations

Immunohistochemistry in the diagnosis of malignant mesothelioma

1987 • 38 citations

The Roles of Immunohistochemistry and Electron Microscopy in Distinguishing Epithelial Mesothelioma of the Pleura from Adenocarcinoma

1996 • 35 citations

The diagnostic value of thrombomodulin immunolocalization in serous effusions.

1995 • 34 citations

Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.

1996 • 34 citations

Distinction of Mesothelioma from Carcinoma in Pleural Effusions

1991 • 33 citations

Quality Control of Immunocytochemical Staining of Effusions Using a Standardized Method of Cell Processing

1996 • 31 citations

A comparative immunohistochemical study of malignant mesothelioma and renal cell carcinoma: the diagnostic utility of Leu‐M1, Ber EP4, Tamm‐Horsfall protein and thrombomodulin

1995 • 29 citations

Newly marketed tissue markers for malignant mesothelioma: Immunoreactivity of rabbit AMAD-2 antiserum compared with monoclonal antibody HBME-1 and a review of the literature on so-called antimesothelioma antibodies

1997 • 29 citations

Identification of Malignant Cells In Serous Effusions Using A Panel of Monoclonal Antibodies Ber‐Ep4, Mca‐B‐12 and Ema

1992 • 25 citations

The Value of Immunohistochemistry of Pleural Biopsy Specimens in the Differential Diagnosis between Malignant Mesothelioma and Metastatic Carcinoma

1994 • 24 citations

The histopathological diagnosis of malignant mesothelioma v. pulmonary adenocarcinoma: reproducibility of the histopathological diagnosis

1994 • 24 citations

Monoclonal Antibodies in Clinical and Experimental Pathology of Lung Cancer

1987 • 23 citations

The immunohistochemistry of malignant mesothelioma.

1994 • 22 citations

Diagnostic histochemical and immunohistochemical studies in malignant mesothelioma

1987 • 18 citations

Differential Expression of CD44S and Hyaluronic Acid in Malignant Mesotheliomas, Adenocarcinomas, and Reactive Mesothelial Hyperplasias

1998 • 18 citations

Immunocytochemical differential diagnosis of diffuse malignant pleural mesotheliomas--a clinicomorphological study of 158 cases.

1991 • 14 citations

Expression of a 130-kDa mesothelial and ciliated cell Ag (MCp130) in normal and developing human and rat lung and its role as a diagnostic marker for mesotheliomas and tumors of the female reproductive system.

1995 • 6 citations